Home/Filings/4/0001415889-24-004107
4//SEC Filing

Golden Lee Scott 4

Accession 0001415889-24-004107

CIK 0001070081other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:10 PM ET

Size

9.0 KB

Accession

0001415889-24-004107

Insider Transaction Report

Form 4
Period: 2024-02-15
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER
Transactions
  • Award

    Common Stock

    2024-02-15+2,60060,514 total
  • Award

    Common Stock

    2024-02-15+20,00057,914 total
  • Award

    Stock Option (Right to Buy)

    2024-02-15+50,00050,000 total
    Exercise: $25.69Exp: 2034-02-14Common Stock (50,000 underlying)
Footnotes (3)
  • [F1]Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025.
  • [F2]Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025.
  • [F3]This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001686217

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:10 PM ET
Size
9.0 KB